Gotu kola (Centella asiatica) is one of the most revered herbs in Ayurvedic medicine, where it has been used for thousands of years to promote longevity, enhance meditation, and treat skin conditions and respiratory infections. Its reputation as a cognitive enhancer in traditional use — the name translates from the Sinhalese as “herb of enlightenment” — has been substantiated by modern research into its effects on neuronal plasticity, collagen synthesis, and the modulation of the stress response. In the cognitive enhancement literature, gotu kola is distinguished from other nootropics by its specific effects on the hippocampus and on the structural plasticity of dendrites and dendritic spines.
Neuronal Plasticity and Dendritic Branching
Neuronal plasticity — the capacity of neurons to form new connections and modify existing ones — is the biological basis of learning and memory. Gotu kola has been shown in multiple animal studies to increase dendritic arborisation — the branching of dendrites — in the hippocampus, specifically increasing the length and complexity of the dendritic tree in pyramidal neurons. The mechanism involves gotu kola’s triterpenoid compounds — asiaticoside, madecassoside, and asiatic acid — which stimulate the synthesis of neurotrophins, particularly brain-derived neurotrophic factor (BDNF). In animal models, gotu kola’s effects on dendritic length and branching are comparable to the effects of a physically enriched environment.
Gotu Kola and Anxiety: The Stress Modulation Effect
Gotu kola is classified as a rasayana in Ayurvedic medicine — a herb that promotes vitality and long life — and its adaptogenic properties have been studied in clinical trials for anxiety and stress reactivity. A double-blind RCT in 33 people with generalised anxiety disorder found that gotu kola at 500mg twice daily for 60 days significantly reduced anxiety scores (Hamilton Anxiety Rating Scale) compared to placebo, with effects that were statistically comparable to the benzodiazepine lorazepam at 1mg twice daily. Importantly, gotu kola did not produce the cognitive impairment or drowsiness associated with benzodiazepines.
Gotu Kola for Skin Health and Wound Healing
Beyond the nervous system, gotu kola has remarkable effects on connective tissue that are relevant for skin health and wound healing. The same triterpenoid compounds that stimulate BDNF production in neurons also stimulate collagen synthesis in skin fibroblasts and accelerate wound contraction — gotu kola-treated wounds show faster closure, better organised collagen deposition, and less scarring in animal models. For skin health applications, gotu kola is used both orally and topically: oral gotu kola at 500-1000mg daily supports collagen synthesis and skin elasticity through the same fibroblast-stimulating mechanism.
Dosing and Safety
The evidence-based dose for cognitive and anxiolytic applications is 500-1000mg of gotu kola extract (standardised to contain at least 10% asiaticoside) daily, split between two doses to maintain stable blood levels. The most significant concern is hepatotoxicity — gotu kola has been associated with rare cases of liver damage, primarily in people taking high doses long-term. Anyone taking gotu kola for extended periods should monitor liver function periodically, particularly if combining with other potentially hepatotoxic compounds.
The Science Behind Methylene Blue Nootropic Effects
Methylene blue is a phenothiazine dye that has been used in medicine for over 140 years — initially as an antimalarial, later as a treatment for methemoglobinemia and cyanide poisoning. Its nootropic properties emerged from observations that at low doses (0.5-4 mg/kg), it acts as an electron donor in the mitochondrial electron transport chain, specifically at Complex I (NADH dehydrogenase). By donating electrons directly to Complex I, methylene blue improves the efficiency of ATP production in neurons, reduces reactive oxygen species generation at Complex III, and enhances mitochondrial respiration. This is particularly relevant for neurons because they are highly energy-dependent and particularly vulnerable to mitochondrial dysfunction.
Memory and Long-Term Potentiation
Studies on animal models demonstrate that methylene blue at low doses enhances long-term potentiation (LTP) — the cellular basis of memory formation in the hippocampus. Methylene blue increases mitochondrial biogenesis in hippocampal neurons, improves calcium handling, and enhances synaptic plasticity-related gene expression. In humans, preliminary studies suggest improvements in short-term memory, working memory, and attention, particularly in tasks requiring sustained concentration. A 2015 study found that methylene blue improved fMRI BOLD signal in the prefrontal cortex during working memory tasks, suggesting increased neural efficiency in the circuits most important for executive function.
Safety and Legality
Methylene blue is FDA-approved for the treatment of methemoglobinemia and is available by prescription. As an over-the-counter supplement ingredient, it occupies a legal grey area — it is not scheduled, but the FDA has issued warning letters to companies marketing it as a supplement. Self-experimentation with methylene blue should only be done with pharmaceutical-grade product at low doses (0.5-2 mg/kg), and it should not be combined with serotonergic medications (SSRIs, MAOIs) due to the risk of serotonin syndrome. At higher doses (above 5 mg/kg), methylene blue acts as a potent MAO inhibitor and carries significant risks.
Leave a Reply